You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 138 No. 1, January 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (4)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Dermatology
 •Dermatology, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Diphencyprone for the Treatment of Alopecia Areata

More Data and New Aspects

Arch Dermatol. 2002;138:112-113.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

IN THE August 2001 issue of the ARCHIVES, Wiseman et al1 presented new and interesting data obtained from a group of 148 consecutive patients who were treated with diphencyprone. The authors provide convincing evidence that this therapeutic modality is associated with a high rate of satisfactory responses that cannot be equaled by any other known treatment.

I agree with the authors that the large range of success rates published in previous studies can be attributed to a lack of uniform definition for "response." Wiseman et al defined a clinically substantial response as "significant regrowth resulting in greater than 75% of the scalp being covered with terminal hair (as determined by the investigators)."

A great advantage of this study is that the patients were homogeneously distributed among 4 different groups showing 25% to 49% hair loss, 50% to 75% hair loss, 75% to 99% hair loss, and 100% hair loss. If . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.